Quantitative assessment of lncRNA H19 polymorphisms and cancer risk: a meta-analysis based on 48,166 subjects

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Sun YS, Zhao Z, Yang ZN, et al. Risk Factors and Preventions of Breast Cancer. Int J Biol Sci. 2017;13(11):1387–1397.
   PubMed Web of Science ®Google Scholar
• VoPham T. Environmental risk factors for liver cancer and nonalcoholic fatty liver disease. Curr Epidemiol Rep. 2019;6(1):50–66.
   PubMedGoogle Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Rojas K, Stuckey A. Breast cancer epidemiology and risk factors. Clin Obstet Gynecol. 2016;59(4):651–672.
   PubMed Web of Science ®Google Scholar
• Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31–54.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Tornesello ML, Buonaguro L, Izzo F, et al. Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections. Oncotarget. 2016;7(18):25087–25102.
   PubMedGoogle Scholar
• Ryan BM. microRNAs in Cancer Susceptibility. Adv Cancer Res. 2017;135:151–171.
   PubMed Web of Science ®Google Scholar
• Thompson CL, Fink SP, Lutterbaugh JD, et al. Genetic variation in 15-hydroxyprostaglandin dehydrogenase and colon cancer susceptibility. PLoS One. 2013;8(5):e64122.
   PubMed Web of Science ®Google Scholar
• Gabory A, Jammes H, Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays. 2010;32(6):473–480.
   PubMed Web of Science ®Google Scholar
• Brannan CI, Dees EC, Ingram RS, et al. The product of the H19 gene may function as an RNA. Mol Cell Biol. 1990;10(1):28–36.
   PubMed Web of Science ®Google Scholar
• Gan L, Lv L, Liao S. Long noncoding RNA H19 regulates cell growth and metastasis via the miR223p/Snail1 axis in gastric cancer. Int J Oncol. 2019;54(6):2157–2168.
   PubMedGoogle Scholar
• Luo M, Li Z, Wang W, et al. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett. 2013;333(2):213–221.
   PubMed Web of Science ®Google Scholar
• Ma C, Nong K, Zhu H, et al. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Tumor Biol. 2014;35(9):9163–9169.
   PubMedGoogle Scholar
• Collette J, Le Bourhis X, Adriaenssens E. Regulation of human breast cancer by the long Non-Coding RNA H19. Int J Mol Sci. 2017;18(11):pii: E2319.
   Web of Science ®Google Scholar
• Sun W, Yang Y, Xu C, et al. Regulatory mechanisms of long noncoding RNAs on gene expression in cancers. Cancer Genet. 2017;216–217:105–110.
   PubMed Web of Science ®Google Scholar
• Raveh E, Matouk IJ, Gilon M, et al. The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory. Mol Cancer. 2015;14(1):184.
   PubMed Web of Science ®Google Scholar
• Safari MR, Mohammad Rezaei F, Dehghan A, et al. Genomic variants within the long non-coding RNA H19 confer risk of breast cancer in Iranian population. Gene. 2019;701:121–124.
   PubMed Web of Science ®Google Scholar
• Hua Q, Lv X, Gu X, et al. Genetic variants in lncRNA H19 are associated with the risk of bladder cancer in a Chinese population. Mutagenesis. 2016;31(5):531–538.
   PubMed Web of Science ®Google Scholar
• Yang C, Tang R, Ma X, et al. Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population. Oncotarget. 2015;6(17):15311–15320.
   PubMedGoogle Scholar
• Yuan Z, Yu Y, Zhang B, et al. Genetic variants in lncRNA H19 are associated with the risk of oral squamous cell carcinoma in a Chinese population. Oncotarget. 2018;9(35):23915–23922.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Imberger G, Thorlund K, Gluud C, et al. False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review. BMJ Open. 2016;6(8):e011890.
   PubMed Web of Science ®Google Scholar
• Abdollahzadeh S, Ghorbian S. Association of the study between LncRNA-H19 gene polymorphisms with the risk of breast cancer. J Clin Lab Anal. 2019;33(3):e22826.
   PubMed Web of Science ®Google Scholar
• Hassanzarei S, Hashemi M, Sattarifard H, et al. Genetic polymorphisms in long noncoding RNA H19 are associated with breast cancer susceptibility in Iranian population. Meta Gene. 2017;14:1–5.
   Web of Science ®Google Scholar
• Verhaegh GW, Verkleij L, Vermeulen SH, et al. Polymorphisms in the H19 gene and the risk of bladder cancer. Eur Urol. 2008;54(5):1118–1126.
   PubMed Web of Science ®Google Scholar
• Yin Z, Cui Z, Li H, et al. Polymorphisms in the H19 gene and the risk of lung Cancer among female never smokers in Shenyang, China. BMC Cancer. 2018;18(1):893.
   PubMedGoogle Scholar
• Li L, Guo G, Zhang H, et al. Association between H19 SNP rs217727 and lung cancer risk in a Chinese population: a case control study. BMC Med Genet. 2018;19(1):136.
   PubMedGoogle Scholar
• Cui P, Zhao Y, Chu X, et al. SNP rs2071095 in LincRNA H19 is associated with breast cancer risk. Breast Cancer Res Treat. 2018;171(1):161–171.
   PubMed Web of Science ®Google Scholar
• Lin Y, Fu F, Chen Y, et al. Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population. Onco Targets Ther. 2017;10:4369–4378.
   PubMed Web of Science ®Google Scholar
• Hu P, Qiao O, Wang J, et al. rs1859168 A > C polymorphism regulates HOTTIP expression and reduces risk of pancreatic cancer in a Chinese population. World J Surg Onc. 2017;15(1):155.
   PubMedGoogle Scholar
• He TD, Xu D, Sui T, et al. Association between H19 polymorphisms and osteosarcoma risk. Eur Rev Med Pharmacol Sci. 2017;21(17):3775–3780.
   PubMed Web of Science ®Google Scholar
• Guo QY, Wang H, Wang Y. LncRNA H19 polymorphisms associated with the risk of OSCC in Chinese population. Eur Rev Med Pharmacol Sci. 2017;21(17):3770–3774.
   PubMed Web of Science ®Google Scholar
• Xia Z, Yan R, Duan F, et al. Genetic polymorphisms in long noncoding RNA H19 are associated with susceptibility to breast cancer in Chinese population. Medicine (Baltimore). 2016;95(7):e2771.
   PubMed Web of Science ®Google Scholar
• Li S, Hua Y, Jin J, et al. Association of genetic variants in lncRNA H19 with risk of colorectal cancer in a Chinese population. Oncotarget. 2016;7(51):25470–25477.
   PubMedGoogle Scholar
• Jin T, Wu X, Yang H, et al. Association of the miR-17-5p variants with susceptibility to cervical cancer in a Chinese population. Oncotarget. 2016;7(47):76647–76655.
   PubMedGoogle Scholar
• Hu C, Yang T, Pan J, et al. Associations between H19 polymorphisms and neuroblastoma risk in Chinese children. Biosci Rep. 2019;39(4):BSR20181582.
   PubMedGoogle Scholar
• Li Z, Niu Y. Association between lncRNA H19 (rs217727, rs2735971 and rs3024270) polymorphisms and the risk of bladder cancer in Chinese population. Minerva Urol Nefrol. 2019;71(2):161–167.
   PubMed Web of Science ®Google Scholar
• Yang ML, Huang Z, Wang Q, et al. The association of polymorphisms in lncRNA-H19 with hepatocellular cancer risk and prognosis. Biosci Rep. 2018;38(5):BSR20171652.
   PubMedGoogle Scholar
• Gong WJ, Yin JY, Li XP, et al. Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response. Tumor Biol. 2016;37(6):8349–8358.
   PubMedGoogle Scholar
• Butt S, Harlid S, Borgquist S, et al. Genetic predisposition, parity, age at first childbirth and risk for breast cancer. BMC Res Notes. 2012;5(1):414.
   PubMedGoogle Scholar
• Barnholtz-Sloan JS, Shetty PB, Guan X, et al. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. Carcinogenesis. 2010;31(8):1417–1423.
   PubMed Web of Science ®Google Scholar
• Song H, Ramus SJ, Kjaer SK, et al. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet. 2009;18(12):2297–2304.
   PubMed Web of Science ®Google Scholar
• Quaye L, Tyrer J, Ramus SJ, et al. Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer. PLoS One. 2009;4(6):e5983.
   PubMed Web of Science ®Google Scholar
• Bhatti P, Doody MM, Alexander BH, et al. Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2007–2011.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.
   PubMed Web of Science ®Google Scholar
• Jarroux J, Morillon A, Pinskaya M. History, Discovery, and Classification of lncRNAs. Adv Exp Med Biol. 2017;1008:1–46.
   PubMed Web of Science ®Google Scholar
• Chu M, Yuan W, Wu S, et al. Quantitative assessment of polymorphisms in H19 lncRNA and cancer risk: a meta-analysis of 13,392 cases and 18,893 controls. Oncotarget. 2016;7(48):78631–78639.
   PubMedGoogle Scholar
• Vennin C, Spruyt N, Dahmani F, et al. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Oncotarget. 2015;6(30):29209–29223.
   PubMedGoogle Scholar
• Kallen AN, Zhou XB, Xu J, et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell. 2013;52(1):101–112.
   PubMed Web of Science ®Google Scholar
• Lv Z, Xu Q, Yuan Y. A systematic review and meta-analysis of the association between long non-coding RNA polymorphisms and cancer risk. Mutat Res. 2017;771:1–14.
   PubMed Web of Science ®Google Scholar